June 3– 7th, 2011 / Chicago, USA

June 3– 7th, 2011 / Chicago, USA

Pharmacokinetic-pharmacodynamic analysis of hepatic artery infusion of three-drug chronomodulated chemotherapy and intravenous cetuximab in patients with liver metastases from colorectal cancer registered in OPTILIV, a european multicenter phase II trial. F. Levi, A. Karaboué, M. C. Etienne-Grimaldi, E. Chatelut, P. F. Innominato, G. Paintaud, P. oukakos, R. Adam, M. Bouchahda, G. Milano. J Clin Oncol 29: 2011 (suppl; abstr e14134).

Safety and efficacy of neoadjuvant combination of hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin with intravenous cetuximab in patients with unresectable liver metastases from colorectal cancer. Interim report from OPTILIV, a european multicenter phase II trial. M. Ducreux, P. Rougier, D. Smith, C. N. J. Focan, P. F. Innominato, M. Bouchahda, Y. Ajavon, D. Castaing, T. De Baere, A. Karaboué, C. Lepere, V. Boige, R. Adam, F. Levi. J Clin Oncol 29: 2011 (suppl; abstr e14102).

Pas de commentaire.

Ajouter un commentaire